A way to block a pain pathway in animal models of chronic neuropathic pain including pain caused by chemotherapeutic agents and bone cancer pain suggesting a promising new approach to pain relief.
In research published in the medical journal Brain, Saint Louis University researcher Daniela Salvemini, Ph.D. and colleagues within SLU, the National Institutes of Health (NIH) and other academic institutions have discovered a way to block a pain pathway in animal models of chronic neuropathic pain including pain caused by chemotherapeutic agents and bone cancer pain suggesting a promising new approach to pain relief.
The scientific efforts led by Salvemini, who is professor of pharmacological and physiological sciences at SLU, demonstrated that turning on a receptor in the brain and spinal cord counteracts chronic nerve pain in male and female rodents. Activating the A3 receptor – either by its native chemical stimulator, the small molecule adenosine, or by powerful synthetic small molecule drugs invented at the NIH – prevents or reverses pain that develops slowly from nerve damage without causing analgesic tolerance or intrinsic reward (unlike opioids).
An Unmet Medical Need
Pain is an enormous problem. As an unmet medical need, pain causes suffering and comes with a multi-billion dollar societal cost. Current treatments are problematic because they cause intolerable side effects, diminish quality of life and do not sufficiently quell pain.
The most successful pharmacological approaches for the treatment of chronic pain rely on certain “pathways”: circuits involving opioid, adrenergic, and calcium channels.
For the past decade, scientists have tried to take advantage of these known pathways – the series of interactions between molecular-level components that lead to pain. While adenosine had shown potential for pain-killing in humans, researchers had not yet successfully leveraged this particular pain pathway because the targeted receptors engaged many side effects.
A Key to Pain Relief
In this research, Salvemini and colleagues have demonstrated that activation of the A3 adenosine receptor subtype is key in mediating the pain relieving effects of adenosine.
“It has long been appreciated that harnessing the potent pain-killing effects of adenosine could provide a breakthrough step towards an effective treatment for chronic pain,” Salvemini said. “Our findings suggest that this goal may be achieved by focusing future work on the A3AR pathway, in particular, as its activation provides robust pain reduction across several types of pain.”
The Latest on: Pain relief
[google_news title=”” keyword=”Pain relief” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Pain relief
- 5 home remedies to get rid of nausea and doctor's No. 1 pick for reliefon April 30, 2024 at 12:36 pm
Nausea can be caused by weight loss drugs, pregnancy, food poisoning, migraines. Doctors share home remedies for nausea, including ginger and peppermint.
- Treatment-related pain may be 'socially contagious'on April 30, 2024 at 11:43 am
An individual's experience of pain from medical treatment can be heightened by witnessing other people's responses to the same treatment, with this negative experience subsequently spreading to others ...
- Lawmakers fall short, again, on property-tax relief | Colorado Springs Gazetteon April 30, 2024 at 10:12 am
To no one’s surprise, pending property tax-relief legislation that will be officially unveiled this week at the Capitol won’t cure what ails Colorado’s homeowners. It won’t even ease their pain ...
- I'm a bed tester — the best mattresses for lower back pain share these key featureson April 30, 2024 at 9:21 am
Everyone needs pressure relief in a mattress, but it’s particularly important if you suffer with aches and pains, including back pain. This is because a lack of pressure relief is often the cause of ...
- Evidence-based integrated approaches provide new opportunities to improve complex pain managementon April 30, 2024 at 8:56 am
Complex Regional Pain Syndrome (CRPS) is a chronic and debilitating pain disorder, typically considered lifelong with limited treatment options. Now, new research finds that early detection and ...
- Salonpas Makes Grand Debut in Nigeria: Unveiling Effective Pain Relief Solutionson April 30, 2024 at 1:22 am
Hisamitsu Pharmaceutical Co. Inc., one of the leading global healthcare companies, has announced the official launch of Salonpas, a trusted pain relief brand in Nigeria. Salonpas is coming to Nigeria ...
- New pain relief patch that's changing the gameon April 29, 2024 at 6:48 am
The following information was submitted by Signal Relief.Signal Relief, an American-based company headquartered in American Fork, Utah with team members in sev ...
- Scientists Make Breakthrough in Chronic Pain Treatmenton April 26, 2024 at 7:53 am
Scientists have developed tiny robotic nerve "cuffs" to diagnose and treat neurological disorders. The flexible devices offer a safer, minimally invasive alternative to today's diagnostics and could ...
- Ovulation Pain and Relief Optionson April 26, 2024 at 6:55 am
Ovulation pain is mild discomfort mid-cycle. Severe pain from ovulation affects your quality of life. Learn what helps with this pain.
- Novaa Lab Reviews – Does It Work For Pain Relief or Fake Red Light Therapy Product?on April 25, 2024 at 1:31 am
NovaaLab stands as a beacon of hope for those seeking natural and effective solutions for pain relief and accelerated recovery. Founded by a visionary biohacker, NovaaLab has pioneered the use of red ...
via Bing News